Aberrant cytokine expression in COVID-19 patients: Associations between cytokines and disease severity. (July 2021)
- Record Type:
- Journal Article
- Title:
- Aberrant cytokine expression in COVID-19 patients: Associations between cytokines and disease severity. (July 2021)
- Main Title:
- Aberrant cytokine expression in COVID-19 patients: Associations between cytokines and disease severity
- Authors:
- Tang, Yueting
Sun, Jiayu
Pan, Huaqin
Yao, Fen
Yuan, Yumeng
Zeng, Mi
Ye, Guangming
Yang, Gui
Zheng, Bokun
Fan, Junli
Pan, Yunbao
Zhao, Ziwu
Guo, Shuang
Liu, Yinjuan
Liao, Fanlu
Duan, Yongwei
Jiao, Xiaoyang
Li, Yirong - Abstract:
- Highlight: IL-6 and IL-10 play a crucial role in the pathogenesis of COVID-19. IL-6 and IL-10 are strictly related to the patients' OS and EFS. Combining IL-6 and IL-10 provide valuable information in predicting prognosis. Dynamic monitoring IL-6 and IL-10 offer the new ideas for COVID-19 therapy. Abstract: Cytokines play pleiotropic, antagonistic, and collaborative in viral disease. The high morbidity and mortality of coronavirus disease 2019 (COVID-19) make it a significant threat to global public health. Elucidating its pathogenesis is essential to finding effective therapy. A retrospective study was conducted on 71 patients hospitalized with COVID-19. Data on cytokines, T lymphocytes, and other clinical and laboratory characteristics were collected from patients with variable disease severity. The effects of cytokines on the overall survival (OS) and event-free survival (EFS) of patients were analyzed. The critically severe and severe patients had higher infection indexes and significant multiple organ function abnormalities than the mild patients ( P < 0.05). IL-6 and IL-10 were significantly higher in the critically severe patients than in the severe and mild patients ( P < 0.05). IL-6 and IL-10 were closely associated with white blood cells, neutrophils, T lymphocyte subsets, D-D dimer, blood urea nitrogen, complement C1q, procalcitonin C-reactive protein. Moreover, the IL-6 and IL-10 levels were closely correlated to dyspnea and dizziness ( P < 0.05). The patientsHighlight: IL-6 and IL-10 play a crucial role in the pathogenesis of COVID-19. IL-6 and IL-10 are strictly related to the patients' OS and EFS. Combining IL-6 and IL-10 provide valuable information in predicting prognosis. Dynamic monitoring IL-6 and IL-10 offer the new ideas for COVID-19 therapy. Abstract: Cytokines play pleiotropic, antagonistic, and collaborative in viral disease. The high morbidity and mortality of coronavirus disease 2019 (COVID-19) make it a significant threat to global public health. Elucidating its pathogenesis is essential to finding effective therapy. A retrospective study was conducted on 71 patients hospitalized with COVID-19. Data on cytokines, T lymphocytes, and other clinical and laboratory characteristics were collected from patients with variable disease severity. The effects of cytokines on the overall survival (OS) and event-free survival (EFS) of patients were analyzed. The critically severe and severe patients had higher infection indexes and significant multiple organ function abnormalities than the mild patients ( P < 0.05). IL-6 and IL-10 were significantly higher in the critically severe patients than in the severe and mild patients ( P < 0.05). IL-6 and IL-10 were closely associated with white blood cells, neutrophils, T lymphocyte subsets, D-D dimer, blood urea nitrogen, complement C1q, procalcitonin C-reactive protein. Moreover, the IL-6 and IL-10 levels were closely correlated to dyspnea and dizziness ( P < 0.05). The patients with higher IL-10 levels had shorter OS than the group with lower levels ( P < 0.05). The older patients with higher levels of single IL-6 or IL-10 tended to have shorter EFS ( P < 0.05), while the patients who had more elevated IL-6 and IL-10 had shorter OS ( P < 0.05). The Cox proportional hazard model revealed that IL-6 was the independent factor affecting EFS. IL-6 and IL-10 play crucial roles in COVID-19 prognosis. … (more)
- Is Part Of:
- Cytokine. Volume 143(2021)
- Journal:
- Cytokine
- Issue:
- Volume 143(2021)
- Issue Display:
- Volume 143, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 143
- Issue:
- 2021
- Issue Sort Value:
- 2021-0143-2021-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-07
- Subjects:
- COVID-19 -- Cytokines -- T lymphocyte -- Disease severity -- Survival
Cytokines -- Periodicals
571.844 - Journal URLs:
- http://www.sciencedirect.com/science/journal/10434666 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.cyto.2021.155523 ↗
- Languages:
- English
- ISSNs:
- 1043-4666
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3506.778000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 16776.xml